BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2704050)

  • 1. Trends in survival from malignant melanoma: remarkable improvement in 23 years.
    Thörn M; Adami HO; Bergström R; Ringborg U; Krusemo UB
    J Natl Cancer Inst; 1989 Apr; 81(8):611-7. PubMed ID: 2704050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
    Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
    Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
    Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
    Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.
    Hollestein LM; van den Akker SA; Nijsten T; Karim-Kos HE; Coebergh JW; de Vries E
    Ann Oncol; 2012 Feb; 23(2):524-30. PubMed ID: 21543630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma incidence and mortality in Scotland 1979-2003.
    MacKie RM; Bray C; Vestey J; Doherty V; Evans A; Thomson D; Nicolson M;
    Br J Cancer; 2007 Jun; 96(11):1772-7. PubMed ID: 17533392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands.
    de Vries E; Houterman S; Janssen-Heijnen ML; Nijsten T; van de Schans SA; Eggermont AM; Coebergh JW
    Ann Oncol; 2007 Jun; 18(6):1110-6. PubMed ID: 17434898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in malignant melanoma incidence and mortality in Wisconsin, 1979-1997.
    Insinga RP; Reither EN; Remington PL; Stephenson-Vine L
    WMJ; 2001; 100(6):27-31. PubMed ID: 11688336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in mortality from malignant melanoma in Sweden, 1970-1996.
    Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Johansson H; Ringborg U
    Cancer; 2000 Jul; 89(2):348-55. PubMed ID: 10918165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant skin melanoma in Estonia: incidence and survival].
    Rakhu MA; Aareleĭd TP; Niĭn ML
    Vopr Onkol; 1987; 33(9):10-4. PubMed ID: 3310397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant melanoma in Scotland 1979-1983.
    MacKie RM; Smyth JF; Soutar DS; Calman KC; Watson AC; Hunter JA; McLaren KM; MacGillivray JB; McPhie JL; Rankin R
    Lancet; 1985 Oct; 2(8460):859-63. PubMed ID: 2864579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.
    Lyth J; Eriksson H; Hansson J; Ingvar C; Jansson M; Lapins J; Månsson-Brahme E; Naredi P; Stierner U; Ullenhag G; Carstensen J; Lindholm C
    Br J Dermatol; 2015 Mar; 172(3):700-6. PubMed ID: 25323770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma signature in Brazil: epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years.
    de Melo AC; Wainstein AJA; Buzaid AC; Thuler LCS
    Melanoma Res; 2018 Dec; 28(6):629-636. PubMed ID: 30204684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and mortality data from cutaneous melanoma in Trentino: registry-based study.
    Boi S; Cristofolini M; Micciolo R; Polla E; Piffer S; Gentilini M
    J Cutan Med Surg; 2008; 12(2):59-63. PubMed ID: 18346401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania.
    Stang A; Valiukeviciene S; Aleknaviciene B; Kurtinaitis J
    Eur J Cancer; 2006 Mar; 42(5):660-7. PubMed ID: 16510281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia.
    de Vries E; Bray FI; Coebergh JW; Parkin DM
    Int J Cancer; 2003 Oct; 107(1):119-26. PubMed ID: 12925966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
    Garbe C; Thiess S; Nürnberger F; Ehlers G; Albrecht G; Lindlar F; Bertz J
    Acta Derm Venereol; 1991; 71(6):506-11. PubMed ID: 1685833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peculiarities of the incidence of cutaneous melanoma].
    Anishchenko IS
    Vopr Onkol; 1980; 26(6):64-7. PubMed ID: 7385732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.